SMS Pharmaceuticals drops after tiny growth in PAT in Q2

SMS Pharmaceuticals dropped 5.22% to Rs 101.75 at 13:30 IST on BSE after net profit rose 0.9% to Rs 9.37 crore on 4.5% drop in net sales to Rs 127.29 crore in Q2 September 2017 over Q2 September 2016.

The result was announced after market hours yesterday, 13 December 2017.

Meanwhile, the S&P BSE Sensex was down 48.94 points or 0.15% at 33,004.10. The S&P BSE Small-Cap index was down 123.69 points or 0.69% at 17,858.16, underperforming the Sensex.

On the BSE, 12,074 shares were traded on the counter so far as against the average daily volumes of 57,704 shares in the past one quarter. The stock had hit a high of Rs 107.75 and a low of Rs 100.90 so far during the day. The stock had hit a 52-week high of Rs 120.90 on 22 September 2017 and a 52-week low of Rs 66.60 on 11 August 2017.

The stock had outperformed the market over the past one month till 13 December 2017, gaining 13% compared with 0.06% gains in the Sensex. The scrip had also outperformed the market in past one quarter, rising 25.26% as against Sensex's 2.69% rise. The scrip had, however, underperformed the market in past one year, gaining 17% as against Sensex's 23.8% rise.

The small-cap company has equity capital of Rs 8.47 crore. Face value per share is Re 1.

SMS Pharmaceuticals is a global player in active pharmaceutical ingredient (API) manufacturing.

Powered by Capital Market - Live News